SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)
Status:
Completed
Trial end date:
2006-05-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the treatment effect of montelukast 10mg on the
primary endpoint of Asthma Control Questionnaire(ACQ), over a 8-week period, in persistent
asthma patients with or without allergic rhinitis.